Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
about
Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complicationIdentification of a renal-specific oxido-reductase in newborn diabetic miceThe effects of oxidative stress on female reproduction: a reviewPimagedine: a novel therapy for diabetic nephropathy.Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation.Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.The maillard reaction in eye diseases.Pyridoxamine: the many virtues of a maillard reaction inhibitor.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Advanced glycation and the immune system: stimulation, inhibition or both?The pathogenesis of diabetic retinopathy: old concepts and new questions.Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity.Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin.Rifampicin reduces advanced glycation end products and activates DAF-16 to increase lifespan in Caenorhabditis elegans.3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs.Pyridorin in type 2 diabetic nephropathy.Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetesPost-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.Inhibition of Advanced Glycation End-Product Formation by Origanum majorana L. In Vitro and in Streptozotocin-Induced Diabetic Rats.Brown pigment formation in heated sugar-protein mixed suspensions containing unmodified and peptically modified whey protein concentrates.Uremic Toxicity of Advanced Glycation End Products in CKD.Lessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic NephropathyMethylglyoxal and glucose metabolism: a historical perspective and future avenues for research.Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycationInhibition of advanced glycation endproduct formation by foodstuffs.Naturally occurring inhibitors against the formation of advanced glycation end-products.Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Glycated proteome: from reaction to intervention.Diabetes-related adduct formation and retinopathy.Have we reached the limits for the treatment of diabetic nephropathy?Advanced glycation end products and diabetic retinopathy.Glycoxidation of biological macromolecules: a critical approach to halt the menace of glycation.Prevention of protein glycation by natural compounds.Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.Advanced glycation End-products (AGEs): an emerging concern for processed food industries.Proteins of Thermus thermophilus are resistant to glycation-induced protein precipitation: an evolutionary adaptation to life at extreme temperatures?A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucoseA theoretical elucidation of glucose interaction with HSA's domains.
P2860
Q26751110-A9382106-3C1D-4787-BD75-9AFBAE651BFEQ28115569-F21D86FD-95FD-4221-B01D-BF1A700B77BBQ28392215-6A358522-9665-4CA1-B612-7ED88A7D079AQ30309168-D246D1CB-3C66-454C-B646-4529AF725DF2Q31561110-BE304B2A-1AF2-4623-BFF4-9D56CAD8F220Q33187854-8F8899BB-47DB-4037-B56E-805A1697AC71Q34436018-7125602E-4C84-4EC6-9669-DE95B86D57FAQ34436025-4E12DC5F-21FC-4A39-9760-03AC69DC5690Q34481838-B3E11B30-8BB5-4AFB-9708-A5C8C318F7DAQ34570629-74FA0E62-9459-4993-B62F-27ECE580AEDBQ34658478-0945ABEC-D472-4FDE-B082-4BADBC0A8298Q34682233-EB937106-B256-4AF6-B321-716C1F2AC3FEQ34816148-736D452F-8CD2-4123-AF71-B8E64237CF55Q35487583-EA3B2407-F066-4DC6-9B8E-30CD134790EFQ35527215-5153E189-EB8D-4F75-A485-3C55B52C6FB0Q35562725-988EB12F-2E03-462A-BFF5-B50EDB168E77Q35720807-B5557FD3-D98F-43B0-8E56-3387313E5A51Q35766899-58847322-B3A8-4245-B178-3A3405B9F594Q36181550-F4DB3196-99CA-4C20-8978-ED02BAFA7700Q36204035-A0C0F108-138C-4DD4-B31B-0D10341E6938Q36248479-EE5154DD-5C81-453B-99B8-D157B811B1CAQ36458598-00E0F26F-535D-4C32-ABA7-1F9FEB89DD54Q36514906-BF5B803B-2D9B-4DF8-AEDC-6BAF1FAAE718Q36734406-199EF22E-4F54-47AC-B5C9-0088188AC6F2Q37183289-092884EE-1E51-4E6F-AD09-719738A272B0Q37230025-7D22B003-BD24-4D47-9875-24EEDCD7346EQ37903707-9561E527-9A80-4865-9098-E88A132DF078Q37903708-B23805EE-4071-4843-A922-DC90164AD68AQ38006722-58D874D5-E239-4D02-A164-2F72E34EBD2FQ38062900-B5B8CFBE-7E64-4B16-A06B-CBDE13B55969Q38070160-FDF5019D-CAB5-4DF8-9D39-C9317C1ECDEAQ38189884-1BF30129-FBCA-45BC-B276-D461DEE61415Q38193463-B8B9C115-D744-45BA-BE44-5DC512F0CE0BQ38221639-4E8B675E-AF47-4126-BA8D-B3057CF41C24Q38358965-7E51ECAE-CC66-400F-B39F-A88A4ED7969AQ38411686-2C3E6FDB-C8B8-4158-88FD-AE2F6C631E23Q38647079-18340B25-374C-408E-B2BA-452D97084709Q39724341-DA2B5F77-97D7-4BC8-97C6-062D3B122C6BQ41817733-B6E0712E-9403-4191-A8EF-21FE6B4C7D5CQ42964667-3FDBB6B2-C9B8-4E33-AE89-12F7E1A44CC4
P2860
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@ast
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@en
type
label
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@ast
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@en
prefLabel
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@ast
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
@en
P356
P1476
Amadorins: novel post-Amadori inhibitors of advanced glycation reactions
@en
P2093
Khalifah RG
P304
P356
10.1006/BBRC.1999.0371
P407
P577
1999-04-01T00:00:00Z